This bill proposes the repeal of RSA 126-Q, which pertains to the New Hampshire Vaccine Association (NHVA). The repeal will eliminate the NHVA's role in collecting payments from commercial payers and third-party administrators, which are currently used to reimburse the Department of Health and Human Services for the non-governmental share of the state's universal vaccine purchasing program for children. As a result of this repeal, the state anticipates a decrease in revenue of approximately $24 million annually, which will also correspond to a decrease in state expenditures by the same amount. The Department of Health and Human Services will need to adjust its operations, including potentially hiring temporary staff to manage the transition and cover costs associated with vaccine purchases during public health emergencies.

The fiscal impact of this bill includes a projected decrease in NHVA revenue and existing vaccine payments, while also potentially increasing insurance premium tax revenue due to higher costs for health insurers. The Insurance Department has indicated that the elimination of the NHVA may lead to increased healthcare costs for insurers, as they would lose access to savings currently provided by the NHVA's purchasing program. This could result in higher premiums and increased administrative costs for insurers, as they would need to process claims for childhood vaccines that are currently managed under the universal purchasing program. The bill is set to take effect 60 days after its passage.